Virulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in India

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Jadhav, Savita ^a   Hussain, Arif ^b   Devi, Savita ^b   Kumar, Ashutosh ^b   Parveen, Sana ^b   Gandham, Nageswari ^a   Wieler, Lothar H ^c   Ewers, Christa ^c   Ahmed, Niyaz ^b,d  

^a HOSPITAL AND RESEARCH CENTRE   (India)

^b UNIVERSITY OF HYDERABAD   (India)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; AMOXICILLIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; NALIDIXIC ACID; NITROFURANTOIN; TETRACYCLINE; BACTERIAL ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL SURFACE; CHILD; CONTROLLED STUDY; CYSTITIS; FECES MICROFLORA; FEMALE; FIMBRIA; GENETIC VARIABILITY; GENOTYPE; GERMANY; HEMAGGLUTINATION; HEMOLYSIS; HUMAN; HYDROPHOBICITY; INCIDENCE; INDIA; INDUSTRIAL AREA; MALE; MOLECULAR PHYLOGENY; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PROSTATITIS; PYELONEPHRITIS; PYREXIA IDIOPATHICA; SCHOOL CHILD; SEPTICEMIA; SEROTYPING; SERUM BACTERICIDAL ACTIVITY; URBAN AREA; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; CASE CONTROL STUDY; CLASSIFICATION; GENETICS; IMMUNOLOGY; MICROBIOLOGICAL EXAMINATION; PATHOGENICITY; PHYLOGENY; POLYMERASE CHAIN REACTION; SEXUAL DEVELOPMENT; SOCIOECONOMICS; URBAN POPULATION; VIRULENCE;

ESCHERICHIA COLI;

ANTIGENS, BACTERIAL; CASE-CONTROL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; INCIDENCE; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; SEROTYPING; SEX CHARACTERISTICS; SOCIOECONOMIC FACTORS; URBAN POPULATION; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

EID: 79953056293     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018063     Document Type: Article

References (38)

1. Fowler JE, Stamey TA, (1977) Studies of introital colonization in women with recurrent urinary infections. The role of bacterial adherence. J Urol 117: 472-476.
2. Dobrindt U, (2005) (Patho-)Genomics of Escherichia coli. Int J Med Microbiol 295: 357-371.
3. Johnson JR, Russo TA, (2005) Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol 295: 383-404.
4. Leffler H, Svanborg-Eden C, (1981) Glycolipid receptors for uropathogenic Escherichia coli on human erythrocytes and uroepithelial cells. Infect Immun 34: 920-929.
5. Hughes C, Hacker J, Roberts A, Goebel W, (1983) Hemolysin production as a virulence marker in symptomatic and asymptomatic urinary tract infections caused by Escherichia coli. Infect Immun 39: 546-551.
6. Hagan EC, Mobley HL, (2007) Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun 75: 3941-3949.
7. Blanco J, Alonso MP, Blanco M, Blanco JE, Gonzalez EA, et al. (1992) Establishment of three categories of P-fimbriated Escherichia coli strains that show different toxic phenotypes and belong to particular O serogroups. FEMS Microbiol Lett 78: 131-136.
8. Blanco M, Blanco J, Blanco JE, Alonso MP, Abalia I, et al. (1995) [Virulence factors and O serogroups of Escherichia coli as a cause of community-acquired urinary infections]. Enferm Infecc Microbiol Clin 13: 236-241.
9. Mathai D, Jones RN, Pfaller MA, (2001) Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis 40: 129-136.
10. Karlowsky JA, Jones ME, Thornsberry C, Critchley I, Kelly LJ, et al. (2001) Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. Int J Antimicrob Agents 18: 121-127.
11. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA, (2001) Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 45: 1402-1406.
12. Dombek PE, Johnson LK, Zimmerley ST, Sadowsky MJ, (2000) Use of repetitive DNA sequences and the PCR To differentiate Escherichia coli isolates from human and animal sources. Appl Environ Microbiol 66: 2572-2577.
13. Quackenbush RL, Falkow S, (1979) Relationship between colicin V activity and virulence in Escherichia coli. Infect Immun 24: 562-564.
14. Collee JG, Duguid JP, Fraser AG, Marmion BP, Simmons A, (1996) Laboratory strategy in the diagnosis of infective syndromes. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie and McCartney practical medical microbiology. 14th ed pp. 53-94 Churchill Livingstone Inc: London.
15. Barron EJ, Fingold MS, (1990) Diagnostic Microbiology. In: Baily, Scott, editors. 8th ed. Mosby Public Philadelphia Toronto, Baltimore pp. 259-260.
16. Ewers C, Li G, Wilking H, Kiessling S, Alt K, et al. (2007) Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: how closely related are they? Int J Med Microbiol 297: 163-176.
17. Clinical and Laboratory Standards Institute (2006) 'Performing standards for antimicrobial susceptibility testing', Fifteenth information supplement Approved standard MS45-A. Wayne, PA.
18. Babypadmini S, Appalaraju B, (2004) Extended spectrum-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae- prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol 22: 172-174.
19. Tankhiwale SS, Jalgaonkar SV, Ahamad S, Hassani U, (2004) Evaluation of extended spectrum beta lactamase in urinary isolates. Indian J Med Res 120: 553-556.
20. Sakoulas G, Eliopoulos GM, Moellering RC Jr, Wennersten C, Venkataraman L, et al. (2002) Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 46: 1492-1502.
21. Siegfried L, Kmetova M, Puzova H, Molokacova M, Filka J, (1994) Virulence-associated factors in Escherichia coli strains isolated from children with urinary tract infections. J Med Microbiol 41: 127-132.
22. Pezzlo M, York MK, (2004) Urine Cultures. In: Isenberg HD, editors. Clinical Microbiology Procedures Handbook 2nd ed Washington D. C. American Society of Microbiology pp. 31211-131231.
23. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, et al. (2009) Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 64: 274-277.
24. Versalovic J, Koeuth T, Lupski JR, (1991) Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 19: 6823-6831.
25. Rademaker JLW, de Bruijn FJ, (1997) Characterization and classification of microbes by rep-PCR genomic fingerprinting and computer-assisted pattern analysis, In: Caetano-Anollés G, Gresshoff PM, editors. DNA markers: protocols, applications, and overviews pp. 151-17 In J. Wiley and Sons, New York, N.Y.
26. Gales AC, Sader HS, Jones RN, (2002) Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000). Diagn Microbiol Infect Dis 44: 289-299.
27. Ulleryd P, (2003) Febrile urinary tract infection in men. Int J Antimicrob Agents 22 (Suppl 2): 89-93.
28. Johnson JR, (1991) Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4: 80-128.
29. Najar GA, Nejad MM, Mansouri S, (2007) The comparison between virulence factors of Escherichia coli isolated from urinary tract infections and fecal flora. Res Pharm Sci 2: 99-103.
30. Jacobsen SM, Stickler DJ, Mobley HL, Shirtliff ME, (2008) Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 21: 26-59.
31. Minshew BH, Jorgensen J, Swanstrum M, Grootes-Reuvecamp GA, Falkow S, (1978) Some characteristics of Escherichia coli strains isolated from extraintestinal infections of humans. J Infect Dis 137: 648-654.
32. Puzova H, Siegfried L, Kmetova M, Filka J, Takacova V, et al. (1994) Fimbriation, surface hydrophobicity and serum resistance in uropathogenic strains of Escherichia coli. FEMS Immunol Med Microbiol 9: 223-229.
33. Johnson JR, (2003) Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Dis clin North Am 17 (2): 261-71.
34. Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, et al. (2010) Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals. J Antimicrob Chemother 65: 651-660.
35. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, et al. (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61: 273-281.
36. Wiles TJ, Kulesus RR, Mulvey MA, (2008) Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol 85: 11-19.
37. Tambekar DH, Dhanorkar DV, Gulhane SR, Khandelwal VK, Dudhane MN, (2006) Antibacterial susceptibility of some urinary tract pathogens to commonly used antibiotics. Afr J Biotechnol 5: 1562-1565.
38. Hannan TJ, Mysorekar IU, Hung CS, Isaacson-Schmid ML, Hultgren SJ, (2010) Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog 6: e1001042.